Lack of sex differences in striatal dopamine D2 receptor binding in drug-naive schizophrenic patients: An IBZM-SPECT study

Psychiatry Research - Neuroimaging

Volumn 130, Issue 1, 2004, Pages 79-84

  Parellada, Eduard ^a   Lomeña, Francisco ^a   Catafau, Ana M ^b   Bernardo, Miquel ^a   Font, Mireia ^a   Fernández Egea, Emilio ^a   Pavía, Javier ^a   Gutierrez, Fernando ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

D2 striatal dopamine receptor; Drug naive; IBZM SPECT; Schizophrenia; Sex

Indexed keywords

BENZODIAZEPINE; DOPAMINE 2 RECEPTOR; IODINE 123; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE; NEUROLEPTIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FRONTAL CORTEX; HUMAN; MALE; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; SCHIZOPHRENIA; SEX DIFFERENCE; SEX RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 1242269952     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2003.05.001     Document Type: Article

References (17)

1. Acton P.D., Pilowsky L.S., Costa D.C., Ell P.J. Multivariate cluster analysis of dynamic iodine-123 iodobenzamide SPET dopamine D2 receptor images in schizophrenia. European Journal of Nuclear Medicine. 24:1997;111-118.
2. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. Fourth ed :1994;APA, Washington, DC.
3. 123I-IBZM SPECT study. Psychiatry Research: Neuroimaging. 107:2001;87-97.
4. Castle D., Murray R.M. The neurodevelopmental basis of sex differences in schizophrenia. Psychological Medicine. 21:1991;565-575.
5. Farde L., Wiesel F.A., Stone-Elander S., Halldin C., Nordstrom A.L., Hall H., Sedvall G. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. Archives of General Psychiatry. 47:1990;213-219.
6. 11C] raclopride in man. Synapse. 20:1995;200-208.
7. Guy, W. (Ed.), 1976. ECDEU Assessment Manual for Psychopharmacology, Revised. [DHEW Publication No. (ADM) 76-338] Superintendent of Documents, US Government Printing Office, Washington, DC.
8. Kaasinen V., Nagren K., Hietala J., Farde L., Rinne J.O. Sex differences in extrastriatal dopamine D2-like receptors in the human brain. American Journal of Psychiatry. 158:2001;308-311.
9. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 13:1987;261-276.
10. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale. Psychological Reports. 10:1962;799-812.
11. 123I-IBZM single photon emission computerised tomography study. British Journal of Psychiatry. 164:1994;16-26.
12. Pohjalainen T., Rinne J.O., Nagren K., Syvälahti E., Hietala J. Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. American Journal of Psychiatry. 155:1998;311-316.
13. Riecher A., Maurer K., Löffler W., Fätkenheuer B., Heiden W., Jörgensen-Munk P. Gender differences in age at onset and course of schizophrenic disorders. A contribution to the understanding of the disease? Häfner H., Gattaz W.F. Search for the Causes of Schizophrenia, vol. II. 1990;Spinger, Berlin, Heidelberg.
14. Seibyl J.P., Woods S.W., Zoghbi S.S., Baldwin R.M., Dey H.M., Goddard A.W. Dynamic computed tomography study. Psychiatry Research: Neuroimaging. 75:1992;115-123.
15. 123I) iodobenzamide single photon emission computed tomography study. Psychiatry Research: Neuroimaging. 75:1997;115-123.
16. 123I-iodobenzamide in chronic schizophrenia. Psychiatry Research: Neuroimaging. 55:1994;111-118.
17. Wong D.F. In vivo imaging of D2 dopamine receptors in schizophrenia. The ups and downs of neuroimaging research. Archives of General Psychiatry. 59:2002;31-34.